Table: begin end state 1 8 cytoplasmic 9 28 transmembrane 29 38 non-cytoplasmic 39 61 transmembrane 62 88 cytoplasmic 89 118 transmembrane 119 140 non-cytoplasmic 141 160 transmembrane 161 168 cytoplasmic 169 188 transmembrane 189 211 non-cytoplasmic 212 235 transmembrane 236 250 cytoplasmic 251 273 transmembrane 274 284 non-cytoplasmic 285 302 transmembrane 303 308 cytoplasmic 309 332 transmembrane 333 351 non-cytoplasmic 352 377 transmembrane 378 383 cytoplasmic 384 401 transmembrane 402 421 non-cytoplasmic 422 442 transmembrane 443 445 cytoplasmic
Input: >WP_104485326.1 NCBI__GCF_002936955.1:WP_104485326.1 MREHFGSRFGFIMAAAGAAVGLGNIWGFPTQAASNGGGAFLIAYLVLVMMLAFPMLVMEV AIGRYGQANPVDSVRKLGRTPLQKTIASLVGYAGMLVPSLVLSFYAIVAGWLLAFLAAAV TRILGWDAATEWLEAFGLGRNIVWTLVFYLLTILVVQAGVRRGIERWSARLMPALFVLFL LLFFYILTQDGAMTGLKHYLVPDFSKVLEPGLLISAMGQAFFSLTIGGCSMLMYGSYLNK NENIPRTAFQVTLLDTGVAFLAGLVILPAMFVAMKNGVTIFAEDGSLLSSDTLVFVVLPA LFDTMGPIGLVMALVFFVLMGIAALTSSISMLEVPVSYTTERFKASRPLMTWLLGGALAL FSVAICLNFGALFGFVIRLSTQNIQPLVGLGFCVLGGWMWGRAKLFEELVQGSPELAGSV FWRIWPWYVRIVCPLLVLLVIGSSW
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server